Adapted from an online social media post:
An 18-year-old girl walked into a clinic with three days of fever. No rash, no bleeding, no red flags. Her dengue tests were all negative — NS1, IgM, IgG — and her blood results showed a stable, improving picture.
Platelets rose from 107 to 125.
Her liver enzymes were elevated (AST 230, ALT 356), but she was hydrated, alert, and clinically well.
Her peripheral blood film hinted at thalassemia minor — later confirmed by her father.
Everything pointed to a simple, safe, outpatient recovery.
And yet, the father insisted on hospital admission.
Not because she was worsening. Not because she needed IV drips or monitoring that couldn’t be done at home. But because — as he admitted plainly — insurance would cover 90% of the inpatient bill, but almost nothing for outpatient clinic care.
Let that sink in.
A hospital stay that would easily cost $3,000–$5,000 versus an outpatient bill that would be less than 10% of that — for the same clinical outcome.
The same IV fluids. The same blood tests. The same doctor overseeing her care.
Except one option rewards the system, and the other penalises it.
This isn’t just a one-off frustration — it’s a symptom of a deeper disease in our healthcare financing model.
When insurers design benefits that encourage hospitalisation over primary care, and when patients learn to “game” those benefits out of financial self-preservation, the result is predictable:
Over-admission.
Inflated premiums.
And ultimately — rising costs that everyone blames on doctors.
Meanwhile, regulators shrug and say no further oversight of insurer-hospital relationships is needed.
So when claims surge and costs spiral, it’s the doctors — not the policy designers — who get accused of “over-servicing.”
The irony? The doctor who saves the patient money by doing what’s medically appropriate — outpatient care — earns less, while the hospital admission that adds no value gets rewarded.
Healthcare shouldn’t be an accounting exercise.
If we truly believe in cost-effective, patient-centred medicine, then the system must stop punishing prudence and start rewarding good judgment.
Until then, “insurance-driven admissions” will remain one of the quietest but costliest distortions in modern healthcare — and once again, the finger will point in the wrong direction.
